Collective price increase of proprietary Chinese medicines2021-12-28
Recently, the prices of proprietary Chinese medicines from several well-known domestic pharmaceutical companies have increased by 10% to 20%, including some common varieties. According to industry insiders, the main reason for the price increase of proprietary Chinese medicines is the general increase in the prices of Chinese medicinal materials. Taking Angong Niuhuang Wan as an example, the prices of all 11 Chinese medicinal materials have risen, ranging from 20% to 50%. The reporter learned from Hebei Anguo, the largest Chinese medicinal material trading center in northern my country, that since December, nearly 80% of Chinese medicinal material prices have risen, and many merchants are holding a wait-and-see attitude, so the transaction volume has declined. For example, the prices of common coptis, honeysuckle, scutellaria, etc. have risen to varying degrees. In addition to common varieties, the price of some expensive medicinal materials has increased more significantly: the prices of saffron, velvet antler, bird’s nest, American ginseng, cordyceps and other varieties have all increased, with price increases ranging from 10% to 50%.